Literature DB >> 27521976

Effects of mood state on impulsivity in pathological buying.

Jennifer Nicolai1, Stefaniá Darancó2, Morten Moshagen3.   

Abstract

Pathological buying is characterized by irrepressible buying behaviour and its negative consequences. A possible mechanism contributing to its development and maintenance is that buying episodes act as a maladaptive strategy to cope with negative emotions. Accordingly, pathological buying has been repeatedly associated with impulsivity, in particular with the tendency to experience strong reactions under negative affect. Relying on an experimental mood induction procedure, the present study tested in a sample of 100 individuals (a) whether individuals with pathological buying symptoms respond more impulsively in the Go/No-Go Task (as a measure of the behavioural inhibition aspect of impulsivity) and (b) whether this association is more pronounced in a negative mood. While controlling for comorbidities, the results show that pathological buying is associated with faster responses and a larger number of commission errors. Moreover, a significant interaction indicated that the association between pathological buying and performance the Go/No-Go Task was stronger in the negative mood condition. The present study thus shows that pathological buying is associated with deficits in the behavioural inhibition component of impulsivity. These deficits are most pronounced when mood is negative; in turn, this provides an explanation for the occurrence of excessive buying episodes following negative affect.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Keywords:  Addictive buying; Compulsive buying; Impulsivity; Mood; Pathological buying

Mesh:

Year:  2016        PMID: 27521976     DOI: 10.1016/j.psychres.2016.08.009

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  An experimental examination of cognitive processes and response inhibition in patients seeking treatment for buying-shopping disorder.

Authors:  Birte Vogel; Patrick Trotzke; Sabine Steins-Loeber; Giulia Schäfer; Jana Stenger; Martina de Zwaan; Matthias Brand; Astrid Müller
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

2.  Cognitive Behavioral Therapy Plus a Serious Game as a Complementary Tool for a Patient With Parkinson Disease and Impulse Control Disorder: Case Report.

Authors:  Teresa Mena-Moreno; Lucero Munguía; Rosario Granero; Ignacio Lucas; Almudena Sánchez-Gómez; Ana Cámara; Yaroslau Compta; Francesc Valldeoriola; Fernando Fernandez-Aranda; Anne Sauvaget; José M Menchón; Susana Jiménez-Murcia
Journal:  JMIR Serious Games       Date:  2022-09-09       Impact factor: 3.364

3.  Which conditions should be considered as disorders in the International Classification of Diseases (ICD-11) designation of "other specified disorders due to addictive behaviors"?

Authors:  Matthias Brand; Hans-JÜrgen Rumpf; Zsolt Demetrovics; Astrid MÜller; Rudolf Stark; Daniel L King; Anna E Goudriaan; Karl Mann; Patrick Trotzke; Naomi A Fineberg; Samuel R Chamberlain; Shane W Kraus; Elisa Wegmann; JoËl Billieux; Marc N Potenza
Journal:  J Behav Addict       Date:  2020-06-30       Impact factor: 7.772

4.  Longitudinal Changes in Gambling, Buying and Materialism in Adolescents: A Population-Based Study.

Authors:  Ana Estévez; Paula Jauregui; Janire Momeñe; Laura Macia; Hibai López-González; Iciar Iruarrizaga; Conchi Riquelme-Ortiz; Roser Granero; Fernando Fernández-Aranda; Cristina Vintró-Alcaraz; Gemma Mestre-Bach; Lucero Munguía; Neus Solé-Morata; Susana Jiménez-Murcia
Journal:  Int J Environ Res Public Health       Date:  2021-03-10       Impact factor: 3.390

5.  The concept of buying-shopping disorder: Comparing latent classes with a diagnostic approach for in-store and online shopping in a representative sample in Switzerland.

Authors:  Mareike Augsburger; Andreas Wenger; Severin Haug; Sophia Achab; Yasser Khazaal; Joël Billieux; Michael P Schaub
Journal:  J Behav Addict       Date:  2020-09-11       Impact factor: 6.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.